gentle patches glp-1 reviews and complaints Claims Evaluated: 2026 Consumer Interest Rises Around Transdermal Wellness Patch Ingredients, Product Lineup, Policy Transparency Gentle Patches GLP-1 Review: Innovation
Description
Consumer genetic testing company 23andMe sees an opportunity to get in on the weight loss boom
Will patients with a BMI of 30 begin with oral options, lower clinical weight loss average %, while a patient with a BMI of 40-50 recommended for higher-efficacy therapies like Retatrutide
It could reshape how we think about obesity, body composition, and metabolic performance
The dual GIP/GLP-1 receptor agonist tirzepatide is among the furthest developed multi-agonists for diabetes care and has so far displayed promising nephroprotective effects
Tested on all skin types and tones
